Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

Opportunities in the pharmaceutical API manufacturing market include leveraging rising demand for complex biologics, ...

A Deloitte survey found that 80% of manufacturing executives plan to allocate at least 20% of their improvement budgets in ...

According to the latest market analysis by Future Market Insights, the global small molecule API market is entering a phase ...

Eli Lilly and Company has announced plans to invest $6.5bn in an active pharmaceutical ingredients (API) manufacturing facility at Generation Park in Houston, in the US state of Texas. The new ...